Screening (oncoscreening). Early cancer diagnostics in Cyber Clinic of Spizhenko.

Cancer morbidity grows not only in Ukraine, it grows throughout the whole world. Oncoscreening is regarded an efficient method for cancer detection at the early stages.

The program of detection of early asymptomatic forms of oncological diseases of different localization is available in Cyber Clinic of Spizhenko.

Recently exactly in the Medical Centre of oncology and radiosurgery Cyber Clinic of Spizhenko the unique MRT in Kyiv is installed. It is Toshiba 1.5 Tesla Vantage Atlas tomograph. Magnetic-resonance imaging in Cyber Clinic of Spizhenko allows to conduct the full specter of diagnostic magnetic-resonance examinations with a unique ability to receive diffusion-weighed images of the whole body (screening-body-scan), but without the radiation load over the patient.

The main weapon of the prophylactic medicine in oncology is oncoscreening.

The aim of screening is to detect the asymptomic cancer at its early stages and define the possible treatment for it. In order to evaluate effectiveness of the screening it is required to conduct the control examinations, preferably MRI with the function Atlas—screening of the whole body. Screening should lead to the decrease of mortality from detected cancer forms. Intermediate features of method effectiveness are decrease of widespread cancer form detection frequency, increase of early stages cancer form detection frequency, and improvement of survival. However, it is impossible to evaluate the screnning only on the basis of the survival. The cancer form, planned for screening, should represent the important problem of healthcare in Ukraine because of the high level of morbidity and mortality after it.

With appearance of “dimensional” tomographs it has become possible to examine the whole body (PET-analogue). The main benefits if tomography of the whole are: fast speed; high informational load; and accuracy.

The examination usually lasts for 1 hour. Tomography of the whole body involves 3-D visualization of the brain, head vessels, neck, lungs, heart, organs of abdominal cavity and of small pelvis, prostate, spine and mammary glands.The program whole-body screening—oncoscreening allows to detect the asymptomatic forms of oncological diseases of different localizations at early stages—including multiple metastases of 1 mm.

The tomography results are given the next day in the form of printed films and the films on CD/DVD – disk. The clinician of MRI and CT examinations prepares the conclusion and consults on the results of screening, gives recommendations about the further observation. When needed, the clinician may suggest additional examinations.

The guarantee for the accuracy of examination is the most modern equipment (the only MRT Toshiba 1.5 Tesla Vantage Atlas in Kyiv) and high professionalism of clinicians.

1. What is the whole-body screening?

In general, whole-body screening creates an image of whole body in 3-D. Screening means diagnostics of the whole body regarding the presence of oncological diseases in a case when there are no vivid symptoms.

2. What is a combination of MRI / CT scannings during screening?

A combination of MRI/CT scannings during the program of detection of early asymptomatic oncological forms of diseases of different localization during screening layers two images, received during the MRI and CT examinations in limits of one procedure. Program (PET-analogue) on the MRT creates color photographs of chemical change (metabolic activity) in tissues. Hence cancer tumor, as a rule, is more active than the normal tissue, the first appears in different colors on the PET-analogue MRI-program.

Combination of CT and MRI in screening can give fuller picture of the tumor localization, its growth, and also it allows to conduct the analysis of the tumor treatment effectiveness, than CT or MRI can do on their own. The results of image receiving in the process of screening, and also of layering of MR and CT films data allow the specialists of the centre of oncology and radiosurgeryCyber Clinic of Spizhenko receive the improved results of screening, and also it allows to answer about the tumor treatment effectiveness. The combination of MRI/CT screening data may also decrease the amount of additional examinations, conducting of procedures required for the detection of early asymptomatic forms of oncological diseases of different localizations. However, this new technology at the current time is available only in the centre of oncology and radiosurgery Cyber Clinic of Spizhenko.

3. Where can I get more detailed information about screening (oncoscreening)?

The additional information about MRI/CT screening can be received in the centre of oncology and radiosurgery Cyber Clinic of Spizhenko. You may connect with our centre of early asymptomatic forms of oncological diseases detection via e-mail: info@cyberclinika.com. Web-site of the centre of oncology and radiosurgery Cyber Clinic of Spizhenko” is located at the Internet domain www.cyberclinika.com.

The screening test should be maximally sensitive and specific. In the literature there are published the results of 8 randomized controlled examinations regarding the investigation of mammographic screening effectiveness. These investigations showed that mammographic screening leads to decrease of mortality from the cancer of mammary glands among the women aged 50-70 years. At the same time screening of women aged less than 50 years, probably, would be not effective. For screening of lung cancer previously it has been suggested to use X-ray examination of chest and cytological examination of sputum. These methods were approbated in 4 randomized controlled examinations and proved ineffective. It has been shown that theirs usage does not decrease mortality from the lung cancer. At this moment there goes on the approbation of spiral computer tomography methods. Big hopes are also put onto the detection of early molecular lung cancer markers.